Literature DB >> 19448214

Hypokalaemia with severe rebound hyperkalaemia after therapeutic barbiturate coma.

Michael J E Neil1, Megan C Dale.   

Abstract

Severe disturbance of potassium balance is a rare but life-threatening complication of therapeutic barbiturate coma. A 14-yr-old patient was treated with a thiopental infusion for management of increased intracranial pressure after severe head injury. The patient had persistent hypokalaemia during the thiopental infusion. On cessation of the infusion the patient rapidly developed a tachydysrhythmia associated with a serum K+ of 7.0. Possible mechanisms of this phenomenon are discussed. We conclude that aggressive treatment of hypokalaemia during barbiturate coma should be avoided, and advocate a tapering dose of thiopental and not abrupt cessation of an infusion. Severe disturbance of plasma potassium balance is a rare but life-threatening complication of therapeutic barbiturate coma. Awareness of this complication should be raised and management altered to less aggressive treatment of hypokalaemia occurring during thiopental infusion, with a tapering dose used on discontinuation to limit a rebound phenomenon.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19448214     DOI: 10.1213/ane.0b013e3181a16418

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  Severe hyperkalemia induced by a short interruption of barbiturate coma.

Authors:  Eleni E Magira; Konstantinos Sakellaridis; Paraskeui Tselioti; Barbara Grammatikopoulou; Athanasios Prekates
Journal:  Intensive Care Med       Date:  2010-11-10       Impact factor: 17.440

Review 2.  Extracellular potassium homeostasis: insights from hypokalemic periodic paralysis.

Authors:  Chih-Jen Cheng; Elizabeth Kuo; Chou-Long Huang
Journal:  Semin Nephrol       Date:  2013-05       Impact factor: 5.299

3.  Strategies for therapeutic hypometabothermia.

Authors:  Shimin Liu; Jiang-Fan Chen
Journal:  J Exp Stroke Transl Med       Date:  2012-01-01

4.  Dyskalaemia associated with thiopentone barbiturate coma for refractory intracranial hypertension: a case series.

Authors:  Shin Yi Ng; Ki Jinn Chin; Tong Kiat Kwek
Journal:  Intensive Care Med       Date:  2011-05-13       Impact factor: 17.440

5.  Falsely elevated sodium levels during thiopental treatment in the ICU: technical interference on a laboratory device with important clinical relevance.

Authors:  Bart F E Feyen; Dries Coenen; Philippe G Jorens; Kristien Wouters; Andrew I R Maas; Viviane Van Hoof; Walter Verbrugghe
Journal:  Neurocrit Care       Date:  2013-02       Impact factor: 3.210

6.  Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.

Authors:  Massimo Antonelli; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Daniel De Backer; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-01-04       Impact factor: 17.440

7.  The effects of propofol and thiopental continuous infusion on serum potassium disturbances in neurosurgical patients.

Authors:  Tae Kyong Kim; Young-Jin Lim; Jae-Woo Ju; Jin Wook Kim; Hee-Pyoung Park
Journal:  J Korean Neurosurg Soc       Date:  2015-03-20

Review 8.  Analgosedation in paediatric severe traumatic brain injury (TBI): practice, pitfalls and possibilities.

Authors:  N Ketharanathan; Y Yamamoto; U Rohlwink; E D Wildschut; M Hunfeld; E C M de Lange; D Tibboel
Journal:  Childs Nerv Syst       Date:  2017-09-06       Impact factor: 1.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.